Dr. Pravin M. Khemani, MD

Dr. Khemani practices at UW Medical Center - Northwest in Seattle, Washington.

Dr. Khemani's NPI, 1457360836, was assigned on August 5, 2006. Dr. Khemani graduated from Wayne State University School of Medicine in 1999. Dr. Khemani holds Washington license MD00044601.

Dr. Khemani's primary practice is UW Medical Center - Northwest, at 1550 N 115th St, Seattle, WA 98133 in King County. The practice phone is (206) 364-0500.

Dr. Khemani's primary practice is UW Medical Center - Northwest in Seattle, Washington. Dr. Khemani is also affiliated with Swedish First Hill Campus. The medical group on file is Swedish Health Services. Dmand AI also links Dr. Khemani to 4 more hospitals, 2 group practices and clinics, 2 medical groups and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khemani practices, 8 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Khemani's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Khemani's licenses on file in 3 states: Washington, California and Texas.

CMS data shows 21,923 Medicare services from Dr. Khemani across 12 procedure codes in 2024, for 455 Medicare patients. Medicare paid $242,359 for them. Every service was in an office.

CMS counts 455 Medicare patients who saw Dr. Khemani in 2024. The largest group is 75 to 84, with 205 patients. 68% of them have parkinson's disease, and 64% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.40, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Khemani's median patient age at 73, with 49% women.

In 2024, Dr. Khemani wrote 4,727 Medicare Part D claims for 620 patients. 78% of them were for generic drugs. CMS names the drug for 4,569 of them, across 46 drugs with 11 or more claims each, at $2,146,073 in total drug cost. In 2023, CMS named 3,868 claims across 41 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Khemani for performance year 2024, reported as part of a group. Dr. Khemani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khemani as offering telehealth. CMS counts 16 procedures of skin biopsy by Dr. Khemani, more than 62% of the clinicians it reports for that procedure.

Dmand AI links 24 papers to Dr. Khemani, published from 2014 to 2023. 2019 was the busiest year, with 3. The most frequent topics are Parkinson Disease, Ataxia and Tremor. Dr. Khemani has published most often in Tremor Other Hyperkinet Mov (N Y). Dr. Khemani's most frequent co-authors are Shilpa Chitnis, MD, Richard Bartens Dewey, MD and Richard Bartens Dewey, MD.

Dmand AI links Dr. Khemani to 4 clinical trials. 1 is still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Dystonia.

CMS Open Payments shows 323 general payments to Dr. Khemani from 23 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 50% of the total. Teva Pharmaceuticals USA, Inc. paid the most, $41,954.

Dr. Khemani graduated from Wayne State University School of Medicine in 1999.